Baird Maintains Neutral on Hinge Health, Raises Price Target to $65
Benzinga Newsdesk 4 months ago
NewsPrice TargetAnalyst Ratings
Baird analyst Vikram Kesavabhotla maintains Hinge Health (NYSE:HNGE) with a Neutral and raises the price target from $55 to $65.
Baird analyst Vikram Kesavabhotla maintains Hinge Health (NYSE:HNGE) with a Neutral and raises the price target from $55 to $65.